Gregory Bell leads CRA’s global life sciences practice. As an expert witness, he frequently testifies on damages in intellectual property, finance and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia and Australia. Dr Bell’s business consulting engagements focus on the economics of business strategy, working with firms to develop sustainable competitive advantages in specific product markets. He has led and consulted to numerous projects concerning game theory and competitive strategy, global launch strategy, product pricing and positioning, capital budgeting and real options, and cost-benefit analyses. Dr Bell is a chartered accountant in Canada and earned his MBA and PhD in business economics from Harvard University.